Results 261 to 270 of about 318,820 (346)
SUN-056 HYPOTHYROIDISM: A FORGOTTEN AND REVERSIBLE CAUSE OF ACUTE KIDNEY INJURY- A SERIES OF 3 CASES
naga sai sri harsha narilla +1 more
openalex +1 more source
Abstract Objective This study was undertaken to explore the motives and predictors of modified Atkins diet (MAD) discontinuation as a treatment of adults with drug‐resistant epilepsy (DRE). Methods A single‐center observational longitudinal study was made of a cohort of patients treated with MAD during the first 6 years at a multidisciplinary ...
Raquel Samões +6 more
wiley +1 more source
Congenital Hypothyroidism: Moving Ahead, but a Long Way Still to Go. [PDF]
Post EM, Heather NL.
europepmc +1 more source
Abstract Objective Hypothalamic hamartomas (HHs) lead to refractory epilepsy, and minimally invasive surgical approaches are standard of care for affected patients. Stereotactic radiofrequency thermocoagulation (SRT) is one of the treatment methods recognized to achieve seizure freedom. This study reports surgical outcome from a single center reporting
Peter Christoph Reinacher +9 more
wiley +1 more source
Exploration of post-PEG precipitation TSH recovery in hypothyroid patients. [PDF]
Yin J, Mei Z, Zhang B, Tang F.
europepmc +1 more source
Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study.
M. Søgaard +5 more
semanticscholar +1 more source
Serum Visfatin Level and Cardiac Valve Calcifcation in Hemodialysis Patients
ABSTRACT Background Cardiac valve calcification is a serious complication in patients with cardiovascular disease. This study investigated the relationship between visfatin levels and cardiac valve calcification in individuals undergoing hemodialysis.
Xiaoqi Wang +5 more
wiley +1 more source
Ogilvie Syndrome in the Setting of Myxedema Ileus: A Case Report. [PDF]
Mounce S, Kim SH, Waymack J.
europepmc +1 more source
ABSTRACT Background Atezolizumab plus bevacizumab (AB) is a standard first‐line therapy for unresectable hepatocellular carcinoma (HCC). However, data on the efficacy and safety of AB rechallenge (re‐AB) after discontinuation are limited. Methods We conducted a retrospective analysis of 13 patients with unresectable HCC who received initial AB ...
Yuichiro Suzuki +13 more
wiley +1 more source

